Table 1 Association of NMI expression with patients’ clinicopathological features in human lung adenocarcinoma (n = 75)
Total adenocarcinoma (N = 75) | NMI low expression (N = 43) | NMI high expression (N = 43) | p | |
|---|---|---|---|---|
Gender | ||||
Male | 39 | 20 (51.3%) | 19 (48.7%) | 0.351 |
Female | 36 | 23 (63.9%) | 13 (36.1%) | |
Age at diagnosis | ||||
< 60 | 43 | 24 (55.8%) | 19 (44.2%) | 0.816 |
≥ 60 | 32 | 19 (59.4%) | 13 (40.6) | |
pT factor | ||||
T1 | 21 | 9 (42.9%) | 12 (57.1%) | 0.443 |
T2 | 42 | 25 (59.5%) | 17 (40.5%) | |
T3 + T4 | 12 | 6 (50%) | 6 (50%) | |
pN factor | ||||
N0 + N1 | 52 | 28 (53.8%) | 24 (46.2%) | 0.4513 |
N2 + N3 + NX | 23 | 15 (65.2%) | 8 (34.8%) | |